369 related articles for article (PubMed ID: 35923105)
1. αvβ1 integrin is enriched in extracellular vesicles of metastatic breast cancer cells: A mechanism mediated by galectin-3.
Zhang DX; Dang XTT; Vu LT; Lim CMH; Yeo EYM; Lam BWS; Leong SM; Omar N; Putti TC; Yeh YC; Ma V; Luo JY; Cho WC; Chen G; Lee VKM; Grimson A; Le MTN
J Extracell Vesicles; 2022 Aug; 11(8):e12234. PubMed ID: 35923105
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of αvβ3 integrin impairs adhesion and uptake of tumor-derived small extracellular vesicles.
Altei WF; Pachane BC; Dos Santos PK; Ribeiro LNM; Sung BH; Weaver AM; Selistre-de-Araújo HS
Cell Commun Signal; 2020 Sep; 18(1):158. PubMed ID: 32988382
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts.
Kong J; Tian H; Zhang F; Zhang Z; Li J; Liu X; Li X; Liu J; Li X; Jin D; Yang X; Sun B; Guo T; Luo Y; Lu Y; Lin B; Liu T
Mol Cancer; 2019 Dec; 18(1):175. PubMed ID: 31796058
[TBL] [Abstract][Full Text] [Related]
4. Human parechovirus 1 utilizes integrins alphavbeta3 and alphavbeta1 as receptors.
Triantafilou K; Triantafilou M; Takada Y; Fernandez N
J Virol; 2000 Jul; 74(13):5856-62. PubMed ID: 10846065
[TBL] [Abstract][Full Text] [Related]
5. The selective regulation of alpha Vbeta 1 integrin expression is based on the hierarchical formation of alpha V-containing heterodimers.
Koistinen P; Heino J
J Biol Chem; 2002 Jul; 277(27):24835-41. PubMed ID: 11997396
[TBL] [Abstract][Full Text] [Related]
6. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.
Ahmed N; Riley C; Rice G; Quinn M
Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicle Integrins Distinguish Unique Cancers.
Hurwitz SN; Meckes DG
Proteomes; 2019 Apr; 7(2):. PubMed ID: 30979041
[TBL] [Abstract][Full Text] [Related]
8. Serum-derived extracellular vesicles from breast cancer patients contribute to differential regulation of T-cell-mediated immune-escape mechanisms in breast cancer subtypes.
Graham R; Gazinska P; Zhang B; Khiabany A; Sinha S; Alaguthurai T; Flores-Borja F; Vicencio J; Beuron F; Roxanis I; Matkowski R; Liam-Or R; Tutt A; Ng T; Al-Jamal KT; Zhou Y; Irshad S
Front Immunol; 2023; 14():1204224. PubMed ID: 37441083
[TBL] [Abstract][Full Text] [Related]
9. Microglia use multiple mechanisms to mediate interactions with vitronectin; non-essential roles for the highly-expressed αvβ3 and αvβ5 integrins.
Welser-Alves JV; Boroujerdi A; Tigges U; Milner R
J Neuroinflammation; 2011 Nov; 8():157. PubMed ID: 22074485
[TBL] [Abstract][Full Text] [Related]
10. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
11. Tenascin-C Induces Phenotypic Changes in Fibroblasts to Myofibroblasts with High Contractility through the Integrin αvβ1/Transforming Growth Factor β/SMAD Signaling Axis in Human Breast Cancer.
Katoh D; Kozuka Y; Noro A; Ogawa T; Imanaka-Yoshida K; Yoshida T
Am J Pathol; 2020 Oct; 190(10):2123-2135. PubMed ID: 32650003
[TBL] [Abstract][Full Text] [Related]
12. Differential Effects of Integrin
Stojanović N; Dekanić A; Paradžik M; Majhen D; Ferenčak K; Ruščić J; Bardak I; Supina C; Tomicic MT; Christmann M; Osmak M; Ambriović-Ristov A
Mol Pharmacol; 2018 Dec; 94(6):1334-1351. PubMed ID: 30262596
[TBL] [Abstract][Full Text] [Related]
13. Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.
Ciardiello C; Leone A; Lanuti P; Roca MS; Moccia T; Minciacchi VR; Minopoli M; Gigantino V; De Cecio R; Rippa M; Petti L; Capone F; Vitagliano C; Milone MR; Pucci B; Lombardi R; Iannelli F; Di Gennaro E; Bruzzese F; Marchisio M; Carriero MV; Di Vizio D; Budillon A
J Exp Clin Cancer Res; 2019 Jul; 38(1):317. PubMed ID: 31319863
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterisation of a tool αvβ1 integrin small molecule RGD-mimetic inhibitor.
Wilkinson AL; Barrett JW; Slack RJ
Eur J Pharmacol; 2019 Jan; 842():239-247. PubMed ID: 30389632
[TBL] [Abstract][Full Text] [Related]
15. Binding of αvβ1 and αvβ6 integrins to tenascin-C induces epithelial-mesenchymal transition-like change of breast cancer cells.
Katoh D; Nagaharu K; Shimojo N; Hanamura N; Yamashita M; Kozuka Y; Imanaka-Yoshida K; Yoshida T
Oncogenesis; 2013 Aug; 2(8):e65. PubMed ID: 23958855
[TBL] [Abstract][Full Text] [Related]
16. Integrin alphavbeta1 is a receptor for foot-and-mouth disease virus.
Jackson T; Mould AP; Sheppard D; King AM
J Virol; 2002 Feb; 76(3):935-41. PubMed ID: 11773368
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Profiling of Extracellular Vesicles Released by Leptin-Treated Breast Cancer Cells: A Potential Role in Cancer Metabolism.
Gelsomino L; Barone I; Caruso A; Giordano F; Brindisi M; Morello G; Accattatis FM; Panza S; Cappello AR; Bonofiglio D; Andò S; Catalano S; Giordano C
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361728
[TBL] [Abstract][Full Text] [Related]
18. Patient pIgR-enriched extracellular vesicles drive cancer stemness, tumorigenesis and metastasis in hepatocellular carcinoma.
Tey SK; Wong SWK; Chan JYT; Mao X; Ng TH; Yeung CLS; Leung Z; Fung HL; Tang AHN; Wong DKH; Mak LY; Yuen MF; Sin CF; Ng IO; Ma SKY; Lee TKW; Cao P; Zhong K; Gao Y; Yun JP; Yam JWP
J Hepatol; 2022 Apr; 76(4):883-895. PubMed ID: 34922977
[TBL] [Abstract][Full Text] [Related]
19. alphaV integrin promotes in vitro and in vivo survival of cells in metastatic melanoma.
Koistinen P; Ahonen M; Kähäri VM; Heino J
Int J Cancer; 2004 Oct; 112(1):61-70. PubMed ID: 15305376
[TBL] [Abstract][Full Text] [Related]
20. αv-Integrin isoform expression in primary human tumors and brain metastases.
Vogetseder A; Thies S; Ingold B; Roth P; Weller M; Schraml P; Goodman SL; Moch H
Int J Cancer; 2013 Nov; 133(10):2362-71. PubMed ID: 23661241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
